Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
04/2003
04/01/2003US6541507 Notably 4,6-dimethoxyindole-2-carboxylic acid and derivatives thereof
04/01/2003US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
04/01/2003US6541490 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt
04/01/2003US6541486 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation.
04/01/2003US6541475 2-nitrostyryl-1-(naphthylmethyl)sulfone for example
04/01/2003US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
04/01/2003US6541473 Resorcinol derivatives
04/01/2003US6541463 Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use
04/01/2003US6541163 Process of powder for bath from natural plants
04/01/2003US6541042 Comprising 5-25% by weight terpinen-4-ol-containing essential oils and 0.01-10% by weight tannin-containing medicinal plants or extracts thereof, used for topical treatment of cutaneous and mucous membrane affections in veterinary sector
04/01/2003US6541008 Vascular endothelial growth factor-like protein from orf viruses binds and activates mammalian VEGF receptor-2, and uses thereof
04/01/2003CA2222309C Composition for treating keratinous material, including at least one silicone-grafted polymer and at least one thickening polymer or copolymer of (meth)acrylamide or a (meth)acrylamide derivative, and uses thereof
03/2003
03/28/2003CA2404045A1 Use of coagulation factor vii-activating protease for the prophylaxis and therapy of vasoproliferative disorders
03/27/2003WO2003025542A2 Immune response associated proteins
03/27/2003WO2003025199A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor
03/27/2003WO2003025155A1 Fermentation product of cyptoporus volvatus and its preparation method and use
03/27/2003WO2003025131A2 Protein modification and maintenance molecules
03/27/2003WO2003025017A1 Cytokine receptor
03/27/2003WO2003025015A2 A soluble toll-like receptor
03/27/2003WO2003025014A2 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
03/27/2003WO2003024966A1 Pteridinone derivatives as modulators of chemokine receptor activity
03/27/2003WO2003024952A1 Bioprecursors for percutaneous application
03/27/2003WO2003024922A1 Hydroxyfattysulfonic acid analogs
03/27/2003WO2003024921A1 Alkyl urea retinoid agonists i
03/27/2003WO2003024920A1 Substituted urea retinoid agonists ii
03/27/2003WO2003024484A1 Remedies for pruritus
03/27/2003WO2003024479A1 Enamel matrix protein compositions for modulating immune response
03/27/2003WO2003024474A2 Anti-inflammatory agent
03/27/2003WO2003024459A1 Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents
03/27/2003WO2003024454A2 Topical composition containing brucine and the use for the treatment of damaged mammalian skin
03/27/2003WO2003024439A1 Phenethanolamine derivatives for treatment of respiratory diseases
03/27/2003WO2003024436A2 Method for treating skin disorders
03/27/2003WO2003024431A1 Device for the administration of an active agent to the human skin
03/27/2003WO2003024422A1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities
03/27/2003WO2003024406A2 Nestin-expressing hair follicle stem cells
03/27/2003WO2003024402A2 Lpa receptor agonists and antagonists and methods of use
03/27/2003WO2003024390A2 Hydroxyeicosenoic acid analogs
03/27/2003WO2003024388A2 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
03/27/2003WO2003002553A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
03/27/2003WO2003000220A3 Use of 1,2-decandiol for combating germs causing body odour
03/27/2003WO2002096358A3 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
03/27/2003WO2002094263A3 Caspase inhibitors and uses thereof
03/27/2003WO2002094019A9 Highly purified antiendotoxin compound
03/27/2003WO2002074237A3 Compositions and methods for the therapy and diagnosis of kidney cancer
03/27/2003WO2002060859A3 Cyclic derivatives as modulators of chemokine receptor activity
03/27/2003WO2002053717A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/27/2003WO2002053100A3 Pharmaceutical dosage form for oral administration of low molecular weight heparin
03/27/2003WO2002053089A3 Stable skin conditioning compositions containing retinoid boosters
03/27/2003WO2002052019A3 22437, a human sulfatase and uses therefor
03/27/2003WO2002048358A3 Regulation of human chemokine-like receptor
03/27/2003WO2002047705A3 Compositions containing an active fraction isolated from tricholoma conglobatum and methods of use
03/27/2003WO2002017880A3 Nitric oxide-producing hydrogel materials
03/27/2003WO2002012340A3 Transporters and ion channels
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003US20030060629 Pyrazine derivatives as modulators of tyrosine kinases
03/27/2003US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders
03/27/2003US20030060507 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders
03/27/2003US20030060492 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
03/27/2003US20030060491 Bicyclic aromatic compounds
03/27/2003US20030060481 The use of scopolamine salts
03/27/2003US20030060473 Piperazine compounds as inhibitors of MMP or TNF
03/27/2003US20030060459 Diamines as modulators of chemokine receptor activity
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003US20030060426 Formulation for protection against oxidative stress containing benzofuranone derivatives
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030060405 Administering to the subject a composition containing the amino acid sequence hexapeptide
03/27/2003US20030059916 IRAK-4: compositions and methods of use
03/27/2003US20030059862 Antibodies against tumor necrosis factor delta (APRIL)
03/27/2003US20030059767 Zinc finger protein derivatives and methods therefor
03/27/2003US20030059462 Dissolving a powder of liposome-forming lipids in an organic solvent to a level close to saturation, adding to the solute obtained a dry, water immiscible carotenoid to obtain a suspension, drying and dehydrating the powder obtained
03/27/2003US20030059451 Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin
03/27/2003US20030059450 Anti-aging formulation containing a cosmeceutically active base, which is a hydroxide- releasing inorganic or nitrogen containing organic base, the formulation has a pH in the range of about 7.5 to 13.0
03/27/2003US20030059447 Compositions comprising a combination of a free sphingoid base and a ceramide and uses thereof
03/27/2003US20030059423 Method for treating symptoms of diabetes
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003CA2460985A1 Nestin-expressing hair follicle stem cells
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460783A1 Bioprecursors for percutaneous application
03/27/2003CA2460704A1 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
03/27/2003CA2460620A1 Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents
03/27/2003CA2460544A1 Anti-inflammatory agent
03/27/2003CA2460460A1 Fermentation product of cryptoporus volvatus and its preparation method and use
03/27/2003CA2460358A1 Hydroxyfattysulfonic acid analogs
03/27/2003CA2460326A1 Method for treating skin disorders
03/27/2003CA2460319A1 Lpa receptor agonists and antagonists and methods of use
03/27/2003CA2460263A1 Hydroxyeicosenoic acid analogs
03/27/2003CA2460151A1 Cytokine receptor
03/27/2003CA2460076A1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities
03/27/2003CA2459773A1 Enamel matrix protein compositions for modulating immune response
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2452288A1 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
03/26/2003EP1295871A1 Vitamin d derivatives
03/26/2003EP1295603A1 The process of extracting from haw-pit by dry distillation and its device
03/26/2003EP1295599A1 Method for the treatment of prevention of atopic dermatitis
03/26/2003EP1295587A1 External preparation for the skin and beautifying agents
03/26/2003EP1294924A2 Method for identifying medically valuable active substances
03/26/2003EP1294905A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
03/26/2003EP1294882A2 B7-like molecules and uses thereof
03/26/2003EP1294874A2 Cd154 variants and uses thereof
03/26/2003EP1294802A1 Polysaccharide based gel
1 ... 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 ... 1065